Table 2 |
|||
|
Clinical variables before and after administration of recombinant human DNase |
|||
|
Variable |
Before |
After |
P |
|
|
|||
|
Heart rate (beats/min) |
150 (121–164) |
130 (115–145) |
0.06 |
|
Respiratory rate |
41 (26–60) |
36 (25–40) |
0.01 |
|
PCO2 (kPa) |
6.55 (5.7–8.6) |
6.00 (5.3–7.5) |
0.005 |
|
FiO2 (%) |
50 (40–100) |
40 (21–75) |
<0.001 |
|
Chest X-ray score |
4 (2–6) |
2 (0–4) |
<0.001 |
|
|
|||
|
Data presented as the median (interquartile range). Comparisons were made using the Wilcoxon signed rank test. |
|||
|
Hendriks et al. Critical Care 2005 9:R351 doi:10.1186/cc3544 |
|||
